Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI

X Yang, C Hu, Z Xing, Y Lin, Y Su, X Wang, D Cao - European Radiology, 2023 - Springer
Objective Noninvasive detection of molecular status of astrocytoma is of great clinical
significance for predicting therapeutic response and prognosis. We aimed to evaluate …
被引用次数：3 相关文章

Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI

X Yang, C Hu, Z Xing, Y Lin, Y Su… - European …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective Noninvasive detection of molecular status of astrocytoma is of great clinical
significance for predicting therapeutic response and prognosis. We aimed to evaluate …

Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI.

X Yang, C Hu, Z Xing, Y Lin, Y Su, X Wang… - European …, 2023 - europepmc.org
Objective Noninvasive detection of molecular status of astrocytoma is of great clinical
significance for predicting therapeutic response and prognosis. We aimed to evaluate …

Prediction of Ki-67 labeling index, ATRX mutation, and MGMT promoter methylation status in IDH-mutant astrocytoma by morphological MRI, SWI, DWI, and DSC-PWI

X Yang, Z Xing, Y Lin, Y Su, C Hu, X Wang… - European Radiology …, 2023 - inis.iaea.org
[en] Noninvasive detection of molecular status of astrocytoma is of great clinical significance
for predicting therapeutic response and prognosis. We aimed to evaluate whether …